CQS
DMAC icon

Credential Qtrade Securities’s DiaMedica Therapeutics DMAC Stock Holding History

Credential Qtrade Securities’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-769
Closed -$3.42K – 347
2021
Q2 		$3.42K Hold
769
– – ﹤0.01% 336
2021
Q1 		$7.04K Hold
769
– – ﹤0.01% 306
2020
Q4 		$7.8K Buy
+769
New +$4.21K ﹤0.01% 288

Other funds holding DMAC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Credential Qtrade Securities's DMAC Position: Q3 2021 in Review

Credential Qtrade Securities sold out of DiaMedica Therapeutics (DMAC) in Q3 2021, closing a stake of 769 shares — an estimated $3.42K sold.

Credential Qtrade Securities first reported a position in DMAC in Q4 2020 and held it in 3 quarters. The position peaked at $7.8K in Q4 2020. 34 funds tracked by Wall St. Rank hold DMAC as of Q3 2021.

  • Credential Qtrade Securities reported no remaining DiaMedica Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Credential Qtrade Securities sold 769 DiaMedica Therapeutics shares in Q3 2021, an estimated $3.42K.
  • Credential Qtrade Securities first reported a position in DiaMedica Therapeutics in Q4 2020 and held it in 3 quarters.
  • Credential Qtrade Securities's DiaMedica Therapeutics position peaked at $7.8K in Q4 2020.
  • 34 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2021.

Based on Credential Qtrade Securities's 13F filing for Q3 2021, filed 21 Jul 2025.